These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 9294665)
1. Evaluation and treatment strategies in patients at high risk of sudden death post myocardial infarction. Underwood RD; Sra J; Akhtar M Clin Cardiol; 1997 Sep; 20(9):753-8. PubMed ID: 9294665 [TBL] [Abstract][Full Text] [Related]
2. Management strategies in patients at high risk of sudden cardiac death following myocardial infarction. Sra J; Underwood RD; Akhtar M Indian Heart J; 1995; 47(2):158-62. PubMed ID: 7590846 [TBL] [Abstract][Full Text] [Related]
3. Pharmacological therapy in coronary heart disease: prevention of life-threatening ventricular tachyarrhythmias and sudden cardiac death. Kochs M; Eggeling T; Hombach V Eur Heart J; 1993 Sep; 14 Suppl E():107-19. PubMed ID: 8223747 [TBL] [Abstract][Full Text] [Related]
5. Risk stratification and clinical outcome of minimally symptomatic and asymptomatic patients with nonsustained ventricular tachycardia and coronary disease: a prospective single-center study. Giorgberidze I; Saksena S; Krol RB; Munsif AN; Kolettis T; Mathew P; Varanasi S; Prakash A; Delfaut P; Lewis CB Am J Cardiol; 1997 Sep; 80(5B):3F-9F. PubMed ID: 9291444 [TBL] [Abstract][Full Text] [Related]
6. Arrhythmic risk stratification of post-myocardial infarction patients. Naccarella F; Lepera G; Rolli A Curr Opin Cardiol; 2000 Jan; 15(1):1-6. PubMed ID: 10666655 [TBL] [Abstract][Full Text] [Related]
7. Can antiarrhythmic drugs survive survival trials? Pratt CM; Waldo AL; Camm AJ Am J Cardiol; 1998 Mar; 81(6A):24D-34D. PubMed ID: 9537220 [TBL] [Abstract][Full Text] [Related]
8. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. Buxton AE; Lee KL; Fisher JD; Josephson ME; Prystowsky EN; Hafley G N Engl J Med; 1999 Dec; 341(25):1882-90. PubMed ID: 10601507 [TBL] [Abstract][Full Text] [Related]
9. The role of antiarrhythmic therapy in the management of nonsustained ventricular tachycardia. Gomes JA Curr Cardiol Rep; 1999 Nov; 1(4):297-301. PubMed ID: 10980857 [TBL] [Abstract][Full Text] [Related]
10. Value of programmed ventricular stimulation in predicting sudden death and sustained ventricular tachycardia in survivors of acute myocardial infarction. Zoni-Berisso M; Molini D; Mela GS; Vecchio C Am J Cardiol; 1996 Apr; 77(9):673-80. PubMed ID: 8651115 [TBL] [Abstract][Full Text] [Related]
11. Electrophysiologic and clinical effects of angiotensin-converting enzyme inhibitors in patients with prior myocardial infarction, nonsustained ventricular tachycardia, and depressed left ventricular function. MUSTT Investigators. Multicenter UnSustained Tachycardia Trial. Singh SN; Karasik P; Hafley GE; Pieper KS; Lee KL; Wyse DG; Buxton AE; Am J Cardiol; 2001 Mar; 87(6):716-20. PubMed ID: 11249889 [TBL] [Abstract][Full Text] [Related]
12. Evaluation and treatment of nonsustained ventricular tachycardia. Wilber DJ Curr Opin Cardiol; 1996 Jan; 11(1):23-31. PubMed ID: 8664529 [TBL] [Abstract][Full Text] [Related]
13. Nonsustained ventricular tachycardia in ischemic heart disease: when and which pharmacological treatment? El-Sherif N; Turitto G Arch Mal Coeur Vaiss; 1996 Feb; 89 Spec No 1():29-32. PubMed ID: 8734161 [TBL] [Abstract][Full Text] [Related]
14. [Stratification of arrhythmia risk and therapeutic options in survivors of acute myocardial infarction]. ArĂ³s Borau F; Loma-Osorio A; Torres Bosco A Rev Esp Cardiol; 1996 Mar; 49(3):157-65. PubMed ID: 8685518 [TBL] [Abstract][Full Text] [Related]
15. Catheter ablation and antiarrhythmic drugs for haemodynamically tolerated post-infarction ventricular tachycardia; long-term outcome in relation to acute electrophysiological findings. Della Bella P; De Ponti R; Uriarte JA; Tondo C; Klersy C; Carbucicchio C; Storti C; Riva S; Longobardi M Eur Heart J; 2002 Mar; 23(5):414-24. PubMed ID: 11846499 [TBL] [Abstract][Full Text] [Related]
16. Amiodarone: what have we learned from clinical trials? Naccarelli GV; Wolbrette DL; Dell'Orfano JT; Patel HM; Luck JC Clin Cardiol; 2000 Feb; 23(2):73-82. PubMed ID: 10676597 [TBL] [Abstract][Full Text] [Related]
17. Treatment of ventricular arrhythmias after recovery from myocardial infarction. Mitchell LB Annu Rev Med; 1994; 45():119-38. PubMed ID: 7515218 [TBL] [Abstract][Full Text] [Related]
18. Clinical and electrophysiologic determinants, treatment and survival of patients with sustained malignant ventricular tachyarrhythmias occurring late after myocardial infarction. Gomes JA; Winters SL; Ergin A; Machac J; Estioko M; Alexopoulous D; Pe E J Am Coll Cardiol; 1991 Feb; 17(2):320-6. PubMed ID: 1991887 [TBL] [Abstract][Full Text] [Related]
19. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. Moss AJ; Hall WJ; Cannom DS; Daubert JP; Higgins SL; Klein H; Levine JH; Saksena S; Waldo AL; Wilber D; Brown MW; Heo M N Engl J Med; 1996 Dec; 335(26):1933-40. PubMed ID: 8960472 [TBL] [Abstract][Full Text] [Related]
20. [Antiarrhythmic therapy in patients with heart failure]. Faber TS; Zehender M Ther Umsch; 2000 May; 57(5):324-32. PubMed ID: 10859993 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]